Fallopian tube adenocarcinoma: common extraperitoneal recurrence

Area of Science:

• Gynecologic Oncology
• Pathology of Female Reproductive System
• Surgical Oncology

Background:

• Fallopian tube adenocarcinoma is an uncommon malignancy within the gynecologic system.
• It exhibits a similar metastatic pattern to epithelial ovarian carcinoma.
• Diagnosis and treatment planning are often challenging due to non-specific symptoms and limited utility of standard diagnostic tools.

Purpose of the Study:

• To analyze the clinical characteristics, treatment outcomes, and prognostic factors for patients with fallopian tube adenocarcinoma.
• To evaluate the effectiveness of surgery, radiation, and chemotherapy in managing this rare tumor.

Main Methods:

• Retrospective review of 30 patients diagnosed with fallopian tube adenocarcinoma between 1954 and 1982.
• Data collected included patient demographics, presenting symptoms, physical findings, diagnostic procedures, and treatment modalities (surgery, radiation, chemotherapy).
• Survival rates were analyzed based on surgical stage and treatment received.

Main Results:

• The mean age of patients was 52 years, with common symptoms including pain, abnormal bleeding, and vaginal discharge.
• Surgical stage was a significant prognostic factor: 14 patients with Stage I and II disease survived 5 years (NED), while no patients with Stage III or IV disease survived 5 years.
• Recurrences occurred up to 6 years post-treatment, with a majority of recurrent sites being extraperitoneal.

Conclusions:

• Surgical stage is a critical determinant of survival in fallopian tube adenocarcinoma.
• Early detection and surgical intervention are crucial for improving patient outcomes.
• The study highlights the need for further research into optimal treatment strategies for advanced-stage disease.